Beamtree Holdings logo
BMT
Health Care Equipment & Services

Beamtree Holdings

Short interest
0.00%
0.00 pp 30d
as of 2 Jan 2026
Reported shorts
1.6K
Shares on issue
290.597M

Beamtree Holdings (BMT) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$29.2M (source: ASX (Markit))vs $28.6M (FY25)
ASX (Markit), as at 14 Oct 2026
NPAT
−$18.3M (source: ASX (Markit))vs −$6.2M (FY25)
ASX (Markit), as at 14 Oct 2026
EPS (diluted)
−$0.063 (source: Derived: trailing 12 months at year end)vs −$0.021 (FY25)
Derived: trailing 12 months at year end, as at 14 Oct 2026
Rev YoY
+2.3%FY
EPS YoY
n/aTTM
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of Appendix 4E and FY26 Annual Report, 28 Aug 2026

Beamtree Holdings reported a 2% revenue increase to $29.2m for FY26, but net loss widened 197% to $18.3m, driven by $13.1m in goodwill and software impairments. No dividend was declared. The company targets increased recurring revenue growth and cost management in FY27, with new CEO Gareth Pye appointed and bank covenants restructured post-period.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
99.8%
Operating margin
−16.7%
Net margin
−62.5%
FCF margin
−10.1%
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
n/a
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

BMT income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$29.2M (source: ASX (Markit))$28.6M$27.8M (source: ASX (Markit))$1.7M
Gross profit$29.2M (source: Derived: trailing 12 months at year end)$28.6Mn/a$1.7M
Operating income−$4.9M (source: Derived: trailing 12 months at year end)−$6.2M−$33.9M−$27.7M
EBITDA$257.0K (source: Derived: trailing 12 months at year end)−$808.0K−$363.0K−$1.3M
EBIT−$4.9M (source: Derived: trailing 12 months at year end)−$6.3M−$5.8M−$6.2M
Interest expensen/a$26.0K$25.0K$34.0K
Pretax income−$18.2M (source: Derived: trailing 12 months at year end)−$6.3M−$5.8M−$6.2M
Tax$86.0K (source: Derived: trailing 12 months at year end)−$191.0K−$724.0K$719.0K
NPAT−$18.3M (source: ASX (Markit))−$6.2M−$5.1M−$6.9M
Net interest income−$186.0K (source: Derived: trailing 12 months at year end)−$121.0K$92.0K−$30.0K
EPS basic−$0.063 (source: Derived: trailing 12 months at year end)−$0.021−$0.018−$0.028
EPS diluted−$0.063 (source: Derived: trailing 12 months at year end)−$0.021−$0.018−$0.028
Sharesn/a290.2M289.0M266.1M
  • ASX (Markit)
  • Derived: trailing 12 months at year end